241 related articles for article (PubMed ID: 38036661)
1. Abelson Helper Integration Site 1 haplotypes and peripheral blood expression associates with lithium response and immunomodulation in bipolar patients.
Sakrajda K; Bilska K; Czerski PM; Narożna B; Dmitrzak-Węglarz M; Heilmann-Heimbach S; Brockschmidt FF; Herms S; Nöthen MM; Cichon S; Więckowska B; Rybakowski JK; Pawlak J; Szczepankiewicz A
Psychopharmacology (Berl); 2024 Apr; 241(4):727-738. PubMed ID: 38036661
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomerase reverse transcriptase positively correlates with duration of lithium treatment in bipolar disorder.
Lundberg M; Biernacka JM; Lavebratt C; Druliner B; Ryu E; Geske J; Colby C; Boardman L; Frye M; Schalling M
Psychiatry Res; 2020 Apr; 286():112865. PubMed ID: 32114208
[TBL] [Abstract][Full Text] [Related]
3. RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.
Milanesi E; Voinsky I; Hadar A; Srouji A; Maj C; Shekhtman T; Gershovits M; Gilad S; Chillotti C; Squassina A; Potash JB; Schulze TG; Goes FS; Zandi P; Kelsoe JR; Gurwitz D
World J Biol Psychiatry; 2019 Jul; 20(6):449-461. PubMed ID: 28854847
[No Abstract] [Full Text] [Related]
4. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
Rybakowski JK
CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
[TBL] [Abstract][Full Text] [Related]
5. Exploring lithium's transcriptional mechanisms of action in bipolar disorder: a multi-step study.
Akkouh IA; Skrede S; Holmgren A; Ersland KM; Hansson L; Bahrami S; Andreassen OA; Steen VM; Djurovic S; Hughes T
Neuropsychopharmacology; 2020 May; 45(6):947-955. PubMed ID: 31652432
[TBL] [Abstract][Full Text] [Related]
6. Cortical thickness and subcortical volumes alterations in euthymic bipolar I patients treated with different mood stabilizers.
Li L; Ji E; Han X; Tang F; Bai Y; Peng D; Fang Y; Zhang S; Zhang Z; Yang H
Brain Imaging Behav; 2019 Oct; 13(5):1255-1264. PubMed ID: 30145720
[TBL] [Abstract][Full Text] [Related]
7. Increased mRNA expression of peripheral glial cell markers in bipolar disorder: The effect of long-term lithium treatment.
Ferensztajn-Rochowiak E; Tarnowski M; Samochowiec J; Michalak M; Ratajczak MZ; Rybakowski JK
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1516-1521. PubMed ID: 27474686
[TBL] [Abstract][Full Text] [Related]
8. Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment.
Squassina A; Meloni A; Congiu D; Bosganas P; Patrinos GP; Lin R; Turecki G; Severino G; Ardau R; Chillotti C; Pisanu C
Hum Genomics; 2022 Oct; 16(1):45. PubMed ID: 36253798
[TBL] [Abstract][Full Text] [Related]
9. Lithium treatment impacts nucleus accumbens shape in bipolar disorder.
Vecchio D; Piras F; Piras F; Banaj N; Janiri D; Simonetti A; Sani G; Spalletta G
Neuroimage Clin; 2020; 25():102167. PubMed ID: 31972398
[TBL] [Abstract][Full Text] [Related]
10. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
11. Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.
Amare AT; Thalamuthu A; Schubert KO; Fullerton JM; Ahmed M; Hartmann S; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hou L; Hsu YH; Shekhtman T; Adli M; Akula N; Akiyama K; Ardau R; Arias B; Aubry JM; Hasler R; Richard-Lepouriel H; Perroud N; Backlund L; Bhattacharjee AK; Bellivier F; Benabarre A; Bengesser S; Biernacka JM; Birner A; Marie-Claire C; Cervantes P; Chen HC; Chillotti C; Cichon S; Cruceanu C; Czerski PM; Dalkner N; Del Zompo M; DePaulo JR; Étain B; Jamain S; Falkai P; Forstner AJ; Frisen L; Frye MA; Gard S; Garnham JS; Goes FS; Grigoroiu-Serbanescu M; Fallgatter AJ; Stegmaier S; Ethofer T; Biere S; Petrova K; Schuster C; Adorjan K; Budde M; Heilbronner M; Kalman JL; Kohshour MO; Reich-Erkelenz D; Schaupp SK; Schulte EC; Senner F; Vogl T; Anghelescu IG; Arolt V; Dannlowski U; Dietrich D; Figge C; Jäger M; Lang FU; Juckel G; Konrad C; Reimer J; Schmauß M; Schmitt A; Spitzer C; von Hagen M; Wiltfang J; Zimmermann J; Andlauer TFM; Fischer A; Bermpohl F; Ritter P; Matura S; Gryaznova A; Falkenberg I; Yildiz C; Kircher T; Schmidt J; Koch M; Gade K; Trost S; Haussleiter IS; Lambert M; Rohenkohl AC; Kraft V; Grof P; Hashimoto R; Hauser J; Herms S; Hoffmann P; Jiménez E; Kahn JP; Kassem L; Kuo PH; Kato T; Kelsoe J; Kittel-Schneider S; Ferensztajn-Rochowiak E; König B; Kusumi I; Laje G; Landén M; Lavebratt C; Leboyer M; Leckband SG; Tortorella A; Manchia M; Martinsson L; McCarthy MJ; McElroy S; Colom F; Millischer V; Mitjans M; Mondimore FM; Monteleone P; Nievergelt CM; Nöthen MM; Novák T; O'Donovan C; Ozaki N; Pfennig A; Pisanu C; Potash JB; Reif A; Reininghaus E; Rouleau GA; Rybakowski JK; Schalling M; Schofield PR; Schweizer BW; Severino G; Shilling PD; Shimoda K; Simhandl C; Slaney CM; Squassina A; Stamm T; Stopkova P; Maj M; Turecki G; Vieta E; Veeh J; Witt SH; Wright A; Zandi PP; Mitchell PB; Bauer M; Alda M; Rietschel M; McMahon FJ; Schulze TG; Clark SR; Baune BT
Mol Psychiatry; 2023 Dec; 28(12):5251-5261. PubMed ID: 37433967
[TBL] [Abstract][Full Text] [Related]
12. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients.
McCarthy MJ; Wei H; Marnoy Z; Darvish RM; McPhie DL; Cohen BM; Welsh DK
Transl Psychiatry; 2013 Oct; 3(10):e318. PubMed ID: 24150227
[TBL] [Abstract][Full Text] [Related]
13. Lithium response in bipolar disorder: Genetics, genomics, and beyond.
Papiol S; Schulze TG; Heilbronner U
Neurosci Lett; 2022 Aug; 785():136786. PubMed ID: 35817312
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments.
Steardo L; Fabrazzo M; Sampogna G; Monteleone AM; D'Agostino G; Monteleone P; Maj M
J Affect Disord; 2019 Feb; 245():174-179. PubMed ID: 30391773
[TBL] [Abstract][Full Text] [Related]
15. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients.
Squassina A; Costa M; Congiu D; Manchia M; Angius A; Deiana V; Ardau R; Chillotti C; Severino G; Calza S; Del Zompo M
Pharmacol Res; 2013 Jul; 73():1-7. PubMed ID: 23619527
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients.
Squassina A; Pisanu C; Congiu D; Caria P; Frau D; Niola P; Melis C; Baggiani G; Lopez JP; Cruceanu C; Turecki G; Severino G; Bocchetta A; Vanni R; Chillotti C; Del Zompo M
Eur Neuropsychopharmacol; 2016 Jul; 26(7):1241-7. PubMed ID: 27084304
[TBL] [Abstract][Full Text] [Related]
18. The effect of mood-stabilizing drugs on cytokine levels in bipolar disorder: A systematic review.
van den Ameele S; van Diermen L; Staels W; Coppens V; Dumont G; Sabbe B; Morrens M
J Affect Disord; 2016 Oct; 203():364-373. PubMed ID: 27344047
[TBL] [Abstract][Full Text] [Related]
19. Lithium and suicide prevention in bipolar disorder.
Benard V; Vaiva G; Masson M; Geoffroy PA
Encephale; 2016 Jun; 42(3):234-41. PubMed ID: 27000268
[TBL] [Abstract][Full Text] [Related]
20. Association study of
Paul P; Nadella RK; Sen S; Ithal D; Mahadevan J; Reddy Y C J; Jain S; Purushottam M; Viswanath B
J Psychopharmacol; 2021 Dec; 35(12):1510-1516. PubMed ID: 34311608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
